We hypothesized that ICAM-1 may be a specific marker for TNBC based on the analysis results, which demonstrated that ICAM-1 was significantly highly expressed in the basal-like breast cancer subtypes and that ICAM-1 expression was highest in the PR-negative group and ER-negative group. The gene discussed is ICAM1; the disease is breast carcinoma.